Home / Business / Business News / Cramer's Investing Club Stock Profile: Drugmaker Abbvie deserves a lot more love from the market

Cramer's Investing Club Stock Profile: Drugmaker Abbvie deserves a lot more love from the market

January 25, 2022 Business, Business News

As we wait for the market to gain more appreciation for Abbvie, the roughly 4.15% dividend handsomely pays us for our patience.

from Business News https://ift.tt/3Iyct7F
via IFTTT https://ift.tt/eA8V8J

No comments

Subscribe to: Post Comments ( Atom )